November 7, 2012

Oramed is a step closer to putting oral insulin on the Map


Oramed is a company developing an oral insulin capsule. The company will be presenting at the 12th Annual Diabetes Technology Society (DTS) Meeting. The DTS is committed to promoting development and use of technology in the fight against diabetes.

The main hurdle in accomplishing the feat of effective oral insulin has been preventing the degradation of insulin when it comes in contact with digestive enzymes This is where Oramed has taken this challenge to Phase II clinical trials. The oral insulin capsule developed by the company is proving itself time and time again.

After a few years of persistent genius, Oramed has been able to engineer, refine, and clinically test the flagship oral insulin capsule. Trials have been completed through Phase 2b, and were shown to be safe and effective in Type 1 diabetes and Type 2 diabetes.

It takes somebody with a vision to persevere and turn the unlikely into the accepted truth. Oramed is made-up of a team of visionaries, researchers, and people who make dreams come true. Keep the faith, Oramed. You have many supporters backing your success who dislike needles!

Visit Your Diabetes Health for more resources about health.